SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-258932
Filing Date
2022-10-06
Accepted
2022-10-06 17:06:08
Documents
15
Period of Report
2022-10-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d378676d8k.htm   iXBRL 8-K 28596
2 EX-3.1 d378676dex31.htm EX-3.1 573790
7 GRAPHIC g378676g03a52.jpg GRAPHIC 11553
  Complete submission text file 0001193125-22-258932.txt   871909

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cnta-20221006.xsd EX-101.SCH 3906
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20221006_def.xml EX-101.DEF 14512
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20221006_lab.xml EX-101.LAB 24198
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20221006_pre.xml EX-101.PRE 15604
9 EXTRACTED XBRL INSTANCE DOCUMENT d378676d8k_htm.xml XML 6046
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 221298687
SIC: 2834 Pharmaceutical Preparations